
Breathing New Life into Long COVID Recovery: How Hyperbaric Oxygen Therapy Could Help
Breathing New Life into Long COVID Recovery: How Hyperbaric Oxygen Therapy Could Help
π¦ Long COVID, the lingering aftermath of COVID-19, has become a frustrating and often debilitating condition for millions worldwide. One of its most commonly reported symptoms is fatigue, deep, unrelenting, and not relieved by rest. Yet despite its impact, effective treatments remain scarce.
A new study offers a glimmer of hope: hyperbaric oxygen therapy (HBOT) may hold real promise for alleviating long COVID symptoms, especially fatigue and brain fog. Here's what we found. π
π‘ What Is HBOT?
Hyperbaric oxygen therapy involves breathing 100% oxygen in a pressurized chamber. Itβs traditionally used to treat conditions like decompression sickness and non-healing wounds. But now, researchers are exploring its potential to help people with long COVID bounce back.
π The Study at a Glance
Ten patients suffering from long COVID-related fatigue participated in this pilot study. Each received 10 HBOT sessions over 12 days.
π
Session details:
* 105 minutes per session
* Three 30-minute periods breathing pure oxygen
* 5-minute air breaks in between
* Pressure: 2.4 atmospheres π‘οΈ
π Participants completed fatigue and cognitive function tests before and after the treatment.
The Results: A Breath of Fresh Air?
The results were nothing short of promising:
β‘ Fatigue: Improved significantly (p=0.0059) with a large effect size (d=1.75)
π§ Global cognition: Notable improvement (p=0.0137)
π§© Executive function & π attention: Marked gains (p<0.005)
π¬ Why This Matters
For many dealing with long COVID, especially younger people who were previously active and working, this condition has been life-changing.
This early research suggests that just 10 sessions of HBOT may lead to statistically and clinically significant improvements in fatigue and cognitive function. π
Long COVID continues to challenge both patients and healthcare providers. But this study gives hope that HBOT could become a powerful new tool in treatment. While more research is needed, the early data is encouraging.
To view the study, click here